Search research articles
Contact Us
Filters
Showing results (31-40 of 516) with videos related to
Page
of 52
Sort By:
Biological & Pharmaceutical Bulletin
|
October 2, 2015
Conformational Effects of the A21G Flemish Mutation on the Aggregation of Amyloid β Peptide
Maho Yagi-Utsumi, Christopher M Dobson
FEBS Letters
|
June 24, 2009
Bridging the gap: from protein misfolding to protein misfolding diseases
Leila M Luheshi, Christopher M Dobson
Methods in Molecular Biology (Clifton, N.J.)
|
August 14, 2012
Nanobodies as structural probes of protein misfolding and fibril formation
Erwin De Genst, Christopher M Dobson
Protein Science : a Publication of the Protein Society
|
October 24, 2003
Chemical modification of insulin in amyloid fibrils
Melanie R Nilsson, Christopher M Dobson
Biochemistry
|
January 15, 2003
In vitro characterization of lactoferrin aggregation and amyloid formation
Melanie R Nilsson, Christopher M Dobson
HFSP Journal
|
May 1, 2009
Characterization of the nucleation barriers for protein aggregation and amyloid formation
Stefan Auer, Christopher M Dobson, Michele Vendruscolo
Journal of Molecular Biology
|
July 5, 2005
A toy model for predicting the rate of amyloid formation from unfolded protein
Damien Hall, Nami Hirota, Christopher M Dobson
Journal of Cellular and Molecular Medicine
|
August 2, 2008
Immunological features of alpha-synuclein in Parkinson's disease
Cintia Roodveldt, John Christodoulou, Christopher M Dobson
Journal of Molecular Biology
|
February 12, 2008
Determination of the transition state ensemble for the folding of ubiquitin from a combination of Phi and Psi analyses
Péter Várnai, Christopher M Dobson, Michele Vendruscolo
Biophysical Journal
|
September 20, 2005
Amyloid fibril formation can proceed from different conformations of a partially unfolded protein
Martino Calamai, Fabrizio Chiti, Christopher M Dobson
Page
of 52
Search research articles
Search
Showing results (31-40 of 516) with videos related to
Sort By:
Page
of 52
Biological & Pharmaceutical Bulletin
|
October 2, 2015
Conformational Effects of the A21G Flemish Mutation on the Aggregation of Amyloid β Peptide
Maho Yagi-Utsumi, Christopher M Dobson
FEBS Letters
|
June 24, 2009
Bridging the gap: from protein misfolding to protein misfolding diseases
Leila M Luheshi, Christopher M Dobson
Methods in Molecular Biology (Clifton, N.J.)
|
August 14, 2012
Nanobodies as structural probes of protein misfolding and fibril formation
Erwin De Genst, Christopher M Dobson
Protein Science : a Publication of the Protein Society
|
October 24, 2003
Chemical modification of insulin in amyloid fibrils
Melanie R Nilsson, Christopher M Dobson
Biochemistry
|
January 15, 2003
In vitro characterization of lactoferrin aggregation and amyloid formation
Melanie R Nilsson, Christopher M Dobson
HFSP Journal
|
May 1, 2009
Characterization of the nucleation barriers for protein aggregation and amyloid formation
Stefan Auer, Christopher M Dobson, Michele Vendruscolo
Journal of Molecular Biology
|
July 5, 2005
A toy model for predicting the rate of amyloid formation from unfolded protein
Damien Hall, Nami Hirota, Christopher M Dobson
Journal of Cellular and Molecular Medicine
|
August 2, 2008
Immunological features of alpha-synuclein in Parkinson's disease
Cintia Roodveldt, John Christodoulou, Christopher M Dobson
Journal of Molecular Biology
|
February 12, 2008
Determination of the transition state ensemble for the folding of ubiquitin from a combination of Phi and Psi analyses
Péter Várnai, Christopher M Dobson, Michele Vendruscolo
Biophysical Journal
|
September 20, 2005
Amyloid fibril formation can proceed from different conformations of a partially unfolded protein
Martino Calamai, Fabrizio Chiti, Christopher M Dobson
Page
of 52